Related Experiment Video
Updated: Jul 9, 2025

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.1K
Is thrombectomy indicated in all ischemic stroke with large vessel occlusion?
Deep K Pujara1, Faisal Al-Shaibi1,2,3, Amrou Sarraj1,2
1University Hospitals Neurological Institute.
Current Opinion in Neurology
|December 6, 2023
Summary
Endovascular thrombectomy (EVT) is a leading treatment for acute ischemic stroke caused by large vessel occlusions. Emerging evidence suggests EVT may benefit additional patient groups, though more randomized trials are needed.
Area of Science:
- Neurology
- Interventional Cardiology
- Vascular Surgery
Background:
- Acute ischemic stroke due to large vessel occlusion (LVO) is a time-sensitive medical emergency.
- Endovascular thrombectomy (EVT) has emerged as a primary treatment for LVO, significantly improving patient outcomes.
- Selected patient populations, including those with large core strokes or extended time windows, are increasingly considered for EVT.
Approach:
- This topical review synthesizes current randomized and nonrandomized evidence on EVT efficacy and safety.
- The review examines EVT application in diverse patient subgroups beyond initial indications.
- It highlights the need for further randomized controlled trials to solidify EVT's role in specific populations.
Key Points:
- EVT is established as first-line therapy for LVO with limited ischemic changes.
- Recent trials support EVT in large core strokes and basilar occlusions up to 24 hours.
- Nonrandomized data suggest potential EVT benefits in mild strokes, distal occlusions, and beyond 24 hours.
Conclusions:
- EVT is a cornerstone treatment for acute ischemic stroke from LVO.
- Evidence supports expanding EVT to select patients with large core strokes and extended time windows.
- Individualized risk-benefit assessment is crucial for EVT decisions in populations lacking definitive randomized evidence.

